Lobular neoplasia on core needle biopsy does not require excision

Cancer

Volumn 112, Issue 10, 2008, Pages 2152-2158

  Nagi, Chandandeep S ^a   O'Donnell, James E ^a   Tismenetsky, Mikhail ^a   Bleiweiss, Ira J ^a   Jaffer, Shabnam M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Core needle biopsy; Correlation; Excision; Lobular neoplasia; Pathologic; Radiologic

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CALCIFICATION; CELL DEATH; CLINICAL PRACTICE; DATA BASE; EXCISION; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS; NEEDLE BIOPSY; NEOPLASM; PRIORITY JOURNAL; RADIOGRAPHY; RADIOLOGY; RISK FACTOR; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 43049104998     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23415     Document Type: Article

References (26)

1. Foote FW Jr, Stewart FW. Lobular carcinoma in situ. A rare form of mammary cancer. Am J Pathol. 1941;17:491-496.
2. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978;42:737-769.
3. Lakhani SR, Audretsch W, Cleton-Jensen AM, et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Eur J Cancer. 2006;42:2205-2211.
4. Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol. 2005;29:534-543.
5. Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology 2004;231:813-819.
6. Bauer VP, Ditkoff BA, Schnabel F, Brenin D. El-Tamer M, Smith S. The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J. 2003;9:4-9.
7. Urban IA. Bilaterality of cancer of the breast: biopsy of the opposite breast. Cancer. 1967;20:1867-1870.
8. Rosen PP, Kosloff C, Lieberman PH, et al. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978:2:3:225-251.
9. Rosen PP, Senie R, Schottenfeld D, et al. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg. 1979;189:3:377-382.
10. Simpson PT, Gale T, Fulford LG, Reis-Filho IS, Lakhani SR. The diagnosis and management of preinvasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res. 2003;5:258-262.
11. Goldstein NS, Vicini FA, Kestin LL, Thomas M. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age. Cancer. 2000;88:2553-2560.
12. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698-2708.
13. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;812:146-151.
14. Page DL, Kidd TE Jr, Dupont WD, et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991;22:1232-1239.
15. Shin S, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med. 2002;126:697-701.
16. Schnitt SI, Morrow M. Lobular carcinoma in situ: current concepts and controversies. Semin Diagn Pathol 1999;16:209-223.
17. Eusebi V, Betts C, Haagensen DE Jr, et al. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study. Hum Pathol. 1984;15:134-140.
18. Merino MI, Livolsi VA. Signet ring carcinoma of the female breast: a clinicopathologic analysis of 24 cases. Cancer. 1981;48:1830-1837.
19. Middleton LP, Palacios DM, Bryant BR, et al. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol. 2000;24:1650-1656.
20. Arpino G, Alred DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM. Lobular neoplasia on core-needle biopsy: clinical significance. Cancer. 2004;101:242-250.
21. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol. 1999;173:291-299.
22. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology 2001;218:503-509.
23. Frykberg E. Lobular carcinoma in situ of the breast. Breast J. 1999;5:296-303.
24. Page DL, Schuyler PA, Dupont WD, et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361:125-129.
25. Middleton LP, Gram S, Stephens T, Stelling CB, Sneige N, Sabin AA. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 2003;16:120-129.
26. Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol. 2002;15:1044-1050.